TTD | Drug: D0H5BG

Drug General Information
Drug ID	D0H5BG
Former ID	DIB019632
Drug Name	compound I3
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[532241]
Structure		Download 2D MOL
Formula	C17H16BrNO
InChI	InChI=1S/C17H16BrNO/c18-15-8-6-12(11-4-2-1-3-5-11)14-10-17(20)16(19)9-7-13(14)15/h1-6,8,16H,7,9-10,19H2
InChIKey	XFZZDIHCNHYESF-UHFFFAOYSA-N
PubChem Compound ID	53494934
PubChem Substance ID	136359704, 164147249, 164160539, 252166766
Target and Pathway
Target(s)	Aminopeptidase N	Target Info	Inhibitor	[532241]
BioCyc Pathway	Glutathione-mediated detoxification
KEGG Pathway	Glutathione metabolism
	Metabolic pathways
	Renin-angiotensin system
	Hematopoietic cell lineage
Pathway Interaction Database	C-MYB transcription factor network
PathWhiz Pathway	Glutathione Metabolism
Reactome	Metabolism of Angiotensinogen to Angiotensins
WikiPathways	Metabolism of Angiotensinogen to Angiotensins
	Cardiac Progenitor Differentiation
	miR-targeted genes in squamous cell - TarBase
	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
	miR-targeted genes in leukocytes - TarBase
	Glutathione metabolism
References
Ref 532241	Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Bioorg Med Chem. 2013 Apr 1;21(7):2135-44.
Ref 532241	Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Bioorg Med Chem. 2013 Apr 1;21(7):2135-44.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information